STAT+: Novartis not ready to admit a $3 billion mistake
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Hello! It’s so damn hot. 
Apologies for the delay in delivery this morning, but I wanted to include a Novartis-pelabresib update from its earnings announcement. It’s the lead item below.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Novartis not ready to admit a $3 billion mistake »
